{"transactions":[{"id":686274,"issuer":{"id":5221,"kind":"organization","name":"MESA LABORATORIES INC /CO/","symbol":"MLAB"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-17T15:49:47.000Z","date":"2026-08-13","kind":"purchase","planned":false,"acquired":true,"shares":7093,"price":112.8,"value":800090.4,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares purchased directly in a private transaction from John Sullivan, Mesa Board Chair by the Anjou Parekh Lifetime Access Trust for which the reporting person's spouse serves as trustee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held by the Anjou Parekh Lifetime Access Trust for which the reporting person's spouse serves as trustee.  The reporting person disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein."}],"balance_after":7093,"source":{"system":"sec-edgar","filing":"0000724004-26-000084","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/724004/000072400426000084/primary_doc.xml","form_type":"4"}},{"id":773878,"issuer":{"id":5221,"kind":"organization","name":"MESA LABORATORIES INC /CO/","symbol":"MLAB"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units - 1","published_at":"2026-05-19T13:04:27.000Z","date":"2026-04-14","kind":"grant","planned":false,"acquired":true,"shares":35236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs that vest 1/3 on each anniversary date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable"}],"balance_after":35236,"derivative":{"underlying":"Common Stock","underlying_shares":35236},"source":{"system":"sec-edgar","filing":"0000724004-26-000034","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/724004/000072400426000034/primary_doc.xml","form_type":"4/A","original_submission_date":"2026-04-24"}},{"id":801443,"issuer":{"id":5221,"kind":"organization","name":"MESA LABORATORIES INC /CO/","symbol":"MLAB"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units - 1","published_at":"2026-04-24T14:49:12.000Z","date":"2026-04-14","kind":"grant","planned":false,"acquired":true,"shares":34807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs that vest 1/3 on each anniversary date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable"}],"balance_after":34807,"derivative":{"underlying":"Common Stock","underlying_shares":34807},"source":{"system":"sec-edgar","filing":"0000724004-26-000033","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/724004/000072400426000033/primary_doc.xml","form_type":"4"}},{"id":1767558,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-10-03T15:42:49.000Z","date":"2023-10-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":645294,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the \"Merger Agreement\"), by and among Bruker Corporation (\"Bruker\"), Bird Mergersub Corporation (\"Merger Sub\") and Phenomex Inc. (the \"Company\"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker, and each outstanding share of Common Stock, par value $0.00005 per share (\"Common Stock\") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the \"Merger Agreement\"), by and among Bruker Corporation (\"Bruker\"), Bird Mergersub Corporation (\"Merger Sub\") and Phenomex Inc. (the \"Company\"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker, and each outstanding share of Common Stock, par value $0.00005 per share (\"Common Stock\") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger, the Reporting Person disposed of all shares of Common Stock beneficially owned by him in exchange for the Merger Consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects shares directly held by Anjou Perekh, TTEE The Anjou Parekh Spousal Lifetime Access Trust DTD 08/10/2023, of which the Reporting Person's spouse is the sole trustee.  The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-019745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000089924323019745/doc4.xml","form_type":"4"}},{"id":1767557,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-10-03T15:42:49.000Z","date":"2023-10-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":595395,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the \"Merger Agreement\"), by and among Bruker Corporation (\"Bruker\"), Bird Mergersub Corporation (\"Merger Sub\") and Phenomex Inc. (the \"Company\"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker, and each outstanding share of Common Stock, par value $0.00005 per share (\"Common Stock\") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the \"Merger Agreement\"), by and among Bruker Corporation (\"Bruker\"), Bird Mergersub Corporation (\"Merger Sub\") and Phenomex Inc. (the \"Company\"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker, and each outstanding share of Common Stock, par value $0.00005 per share (\"Common Stock\") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger, the Reporting Person disposed of all shares of Common Stock beneficially owned by him in exchange for the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-019745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000089924323019745/doc4.xml","form_type":"4"}},{"id":1789637,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-09-05T16:53:49.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4816},"source":{"system":"sec-edgar","filing":"0001209191-23-048185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048185/doc4.xml","form_type":"4"}},{"id":1789636,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-09-05T16:53:49.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3788},"source":{"system":"sec-edgar","filing":"0001209191-23-048185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048185/doc4.xml","form_type":"4"}},{"id":1789635,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2023-09-05T16:53:49.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3739,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger (the \"Effective Time\"), each share of the Issuer's common stock issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive 0.75 shares of Class A common stock of Globus  (\"Globus Class A Common Stock\"), par value $0.001 per share (the \"Exchange Ratio\" and such shares, the \"Merger Consideration\"), and cash in lieu of fractional shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-048185","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048185/doc4.xml","form_type":"4"}},{"id":1795321,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-28T16:10:42.000Z","date":"2023-08-24","kind":"gift","planned":false,"acquired":true,"shares":645294,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift of 645,294 shares by the Reporting Person to Anjou Perekh, TTEE The Anjou Parekh Spousal Lifetime Access Trust DTD 08/10/2023, of which the Reporting Person's spouse is the sole trustee, in connection with estate planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects shares directly held by Anjou Perekh, TTEE The Anjou Parekh Spousal Lifetime Access Trust DTD 08/10/2023, of which the Reporting Person's spouse is the sole trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":645294,"source":{"system":"sec-edgar","filing":"0001104659-23-095987","document":"tm2324970-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000110465923095987/tm2324970-1_4seq1.xml","form_type":"4"}},{"id":1795320,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-28T16:10:42.000Z","date":"2023-08-24","kind":"gift","planned":false,"acquired":false,"shares":645294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift of 645,294 shares by the Reporting Person to Anjou Perekh, TTEE The Anjou Parekh Spousal Lifetime Access Trust DTD 08/10/2023, of which the Reporting Person's spouse is the sole trustee, in connection with estate planning purposes."}],"balance_after":595395,"source":{"system":"sec-edgar","filing":"0001104659-23-095987","document":"tm2324970-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000110465923095987/tm2324970-1_4seq1.xml","form_type":"4"}},{"id":1859241,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2023-06-12T17:53:39.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":4816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2024 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 8, 2023, Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Globus Medical, Inc. (\"Globus Medical\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Globus Medical. The Merger Agreement provides, among other things, that subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will merge with and into Issuer (the \"Merger\"), with Issuer surviving the Merger as a wholly owned subsidiary of Globus Medical. Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each RSU outstanding immediately prior to the Effective Time held by the Reporting Person will fully vest and be cancelled and converted automatically into the right to receive (without interest) 0.75 fully paid and non-assessable shares of Class A common stock of Globus Medical (and cash in lieu of any fractional shares) in respect of each share of Issuer's common stock underlying such RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2024 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 8, 2023, Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Globus Medical, Inc. (\"Globus Medical\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Globus Medical. The Merger Agreement provides, among other things, that subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will merge with and into Issuer (the \"Merger\"), with Issuer surviving the Merger as a wholly owned subsidiary of Globus Medical. Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each RSU outstanding immediately prior to the Effective Time held by the Reporting Person will fully vest and be cancelled and converted automatically into the right to receive (without interest) 0.75 fully paid and non-assessable shares of Class A common stock of Globus Medical (and cash in lieu of any fractional shares) in respect of each share of Issuer's common stock underlying such RSU."}],"balance_after":4816,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4816},"source":{"system":"sec-edgar","filing":"0001209191-23-036454","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123036454/doc4.xml","form_type":"4"}},{"id":1965938,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-07T21:34:23.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":317029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units which vested in full on March 3, 2023. The restricted stock units were granted pursuant to the Issuer's 2020 Incentive Award Plan in lieu of a cash bonus earned for 2022. Restricted stock units were settled in shares of the Issuer's common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 765,741 restricted stock units."}],"balance_after":1240689,"source":{"system":"sec-edgar","filing":"0001104659-23-029760","document":"tm237589-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000110465923029760/tm237589-5_4seq1.xml","form_type":"4"}},{"id":2088032,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-13T16:46:07.000Z","date":"2022-12-09","kind":"tax_withholding","acquired":false,"shares":36975,"price":2.64,"value":97614.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares sold by the Reporting Person pursuant to a pre-determined election in order to cover tax withholding obligations incurred in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 765,741 restricted stock units."}],"balance_after":923660,"source":{"system":"sec-edgar","filing":"0001104659-22-126646","document":"tm2232538-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000110465922126646/tm2232538-1_4.xml","form_type":"4"}},{"id":2091136,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-09T16:10:53.000Z","date":"2022-12-07","kind":"tax_withholding","acquired":false,"shares":150,"price":2.53,"value":379.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares sold by the Reporting Person pursuant to a pre-determined election in order to cover tax withholding obligations incurred in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 850,505 restricted stock units."}],"balance_after":960635,"source":{"system":"sec-edgar","filing":"0001104659-22-125847","document":"tm2232312-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000110465922125847/tm2232312-1_4.xml","form_type":"4"}},{"id":2160171,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-13T19:19:58.000Z","date":"2022-09-09","kind":"tax_withholding","acquired":false,"shares":29200,"price":3.96,"value":115632.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares sold by the Reporting Person pursuant to a pre-determined election in order to cover tax withholding obligations incurred in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 850,914 restricted stock units."}],"balance_after":960785,"source":{"system":"sec-edgar","filing":"0001567619-22-017383","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000156761922017383/doc1.xml","form_type":"4"}},{"id":2162324,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-09T17:23:51.000Z","date":"2022-09-07","kind":"tax_withholding","acquired":false,"shares":561,"price":3.68,"value":2064.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares sold by the Reporting Person pursuant to a pre-determined election in order to cover tax withholding obligations incurred in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 935,679 restricted stock units."}],"balance_after":989985,"source":{"system":"sec-edgar","filing":"0001567619-22-017239","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000156761922017239/doc1.xml","form_type":"4"}},{"id":2224920,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-06-21T13:45:59.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":89047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in full on the earlier of (i) the first anniversary of the date of grant or (ii) the day prior to the date of the next annual shareholders meeting"}],"balance_after":89047,"derivative":{"exercise_price":2.1,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":89047},"source":{"system":"sec-edgar","filing":"0001062993-22-015244","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573666/000106299322015244/form4.xml","form_type":"4"}},{"id":2234186,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-13T18:20:06.000Z","date":"2022-06-09","kind":"tax_withholding","acquired":false,"shares":31531,"price":5.22,"value":164591.82,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 937,312 restricted stock units."}],"balance_after":990546,"source":{"system":"sec-edgar","filing":"0001567619-22-012800","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000156761922012800/doc1.xml","form_type":"4"}},{"id":2249798,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2022-06-01T16:53:16.000Z","date":"2022-05-28","kind":"exercise","acquired":false,"shares":2702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This RSU award was granted to the Reporting Person on May 18, 2021. In accordance with the terms of the RSU award, the award vested as to 2,702 shares on May 11, 2022. Pursuant to a deferral election made by the Reporting Person, all of the shares underlying the RSUs were delivered on May 28, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This RSU award was granted to the Reporting Person on May 18, 2021. In accordance with the terms of the RSU award, the award vested as to 2,702 shares on May 11, 2022. Pursuant to a deferral election made by the Reporting Person, all of the shares underlying the RSUs were delivered on May 28, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2702},"source":{"system":"sec-edgar","filing":"0001209191-22-033194","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919122033194/doc4.xml","form_type":"4"}},{"id":2249797,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2022-06-01T16:53:16.000Z","date":"2022-05-28","kind":"exercise","acquired":false,"shares":1037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This RSU award was granted to the Reporting Person on February 1, 2021. In accordance with the terms of the RSU award, the award vested as to 1,037 shares on May 18, 2021. Pursuant to a deferral election made by the Reporting Person, all of the shares underlying the RSUs were delivered on May 28, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This RSU award was granted to the Reporting Person on February 1, 2021. In accordance with the terms of the RSU award, the award vested as to 1,037 shares on May 18, 2021. Pursuant to a deferral election made by the Reporting Person, all of the shares underlying the RSUs were delivered on May 28, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1037},"source":{"system":"sec-edgar","filing":"0001209191-22-033194","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919122033194/doc4.xml","form_type":"4"}},{"id":2249796,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-01T16:53:16.000Z","date":"2022-05-28","kind":"exercise","acquired":true,"shares":3739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards."}],"balance_after":3739,"source":{"system":"sec-edgar","filing":"0001209191-22-033194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919122033194/doc4.xml","form_type":"4"}},{"id":2272334,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2022-05-13T17:56:18.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":3788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2023 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until May 28, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2023 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until May 28, 2022."}],"balance_after":3788,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3788},"source":{"system":"sec-edgar","filing":"0001209191-22-028939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919122028939/doc4.xml","form_type":"4"}},{"id":2321452,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-22T21:43:15.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":678118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest subject to both a service-based requirement and a performance-based requirement, where (i) the service-based requirement shall be satisfied with respect to 20% of the stock option shares on each anniversary of the Appointment Date, and (ii) the performance-based requirement will be satisfied with respect to 20% of the stock options shares based on achieving each of the stock option price goals of 200%, 400%, 800%, 1500% and 2000% of $5.93, which such stock price goals must be achieved by the seventh anniversary of the Appointment Date."}],"balance_after":678118,"derivative":{"exercise_price":5.69,"expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":678118},"source":{"system":"sec-edgar","filing":"0001567619-22-007363","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000156761922007363/doc1.xml","form_type":"4"}},{"id":2321451,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-22T21:43:15.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":339059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in twelve (12) equal quarterly installments on each quarterly anniversary from the Appointment Date."}],"balance_after":339059,"derivative":{"exercise_price":5.69,"expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":339059},"source":{"system":"sec-edgar","filing":"0001567619-22-007363","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000156761922007363/doc1.xml","form_type":"4"}},{"id":2321450,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-22T21:43:15.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":1017177,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units which will vest in twelve (12) equal quarterly installments beginning from the date that is one quarterly anniversary after March 9, 2022 (the \"Appointment Date\")."}],"balance_after":1022077,"source":{"system":"sec-edgar","filing":"0001567619-22-007363","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000156761922007363/doc1.xml","form_type":"4"}},{"id":2574820,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-09T21:17:19.000Z","date":"2021-09-07","kind":"grant","acquired":true,"shares":4900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in 36 equal monthly installments until fully vested on September 7, 2024."}],"balance_after":4900,"derivative":{"exercise_price":37.35,"expiration_date":"2031-09-06","underlying":"Common Stock","underlying_shares":4900},"source":{"system":"sec-edgar","filing":"0001567619-21-016931","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000156761921016931/doc1.xml","form_type":"4"}},{"id":2574819,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-09T21:17:19.000Z","date":"2021-09-07","kind":"grant","acquired":true,"shares":4900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units which will vest with respect to one-third of the shares on September 7, 2022, and will vest with respect to the remainder of the shares in equal quarterly installments thereafter until fully vested on September 7, 2024. The restricted stock units will be settled in shares of the Issuer's common stock upon vesting."}],"balance_after":4900,"source":{"system":"sec-edgar","filing":"0001567619-21-016931","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000156761921016931/doc1.xml","form_type":"4"}},{"id":2703558,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2021-05-20T17:52:07.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":2702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2022 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until May 28, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2022 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until May 28, 2022."}],"balance_after":2702,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2702},"source":{"system":"sec-edgar","filing":"0001209191-21-034549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919121034549/doc4.xml","form_type":"4"}},{"id":2882436,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":23131,"kind":"person","name":"Kadia Siddhartha","position":1,"cik":"0001573666","reported_name":"Kadia Siddhartha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2021-02-03T17:55:18.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":1037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on May 18, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on May 18, 2021."}],"balance_after":1037,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1037},"source":{"system":"sec-edgar","filing":"0001209191-21-007396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919121007396/doc4.xml","form_type":"4"}}]}